{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:42:26Z","timestamp":1776300146744,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01AI088770"],"award-info":[{"award-number":["R01AI088770"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.vaccine.2018.04.089","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T01:03:31Z","timestamp":1526605411000},"page":"3842-3852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats"],"prefix":"10.1016","volume":"36","author":[{"given":"Jessica L.","family":"Grieves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"Garcia-Sastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Mena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Peeples","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi P.","family":"Risman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Federman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marvin J.","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell K.","family":"Durbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan E.","family":"Durbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2018.04.089_b0005","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1086\/322657","article-title":"Respiratory syncytial virus infections in previously healthy working adults","volume":"33","author":"Hall","year":"2001","journal-title":"Clin Infect Diseases: Off Publ Infect Diseases Soc Am"},{"issue":"5","key":"10.1016\/j.vaccine.2018.04.089_b0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/00019053-200422050-00001","article-title":"Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases","volume":"22","author":"Paramore","year":"2004","journal-title":"PharmacoEconomics"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.089_b0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archotol.135.1.17","article-title":"Rate of concurrent otitis media in upper respiratory tract infections with specific viruses","volume":"135","author":"Alper","year":"2009","journal-title":"Arch Otolaryngol \u2013 Head Neck Surg"},{"issue":"4","key":"10.1016\/j.vaccine.2018.04.089_b0020","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of reinfection with respiratory syncytial virus","volume":"163","author":"Hall","year":"1991","journal-title":"J Infect Diseases"},{"issue":"2 Suppl","key":"10.1016\/j.vaccine.2018.04.089_b0025","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/01.inf.0000053881.47279.d9","article-title":"Impact of severe disease caused by respiratory syncytial virus in children living in developed countries","volume":"22","author":"Simoes","year":"2003","journal-title":"Pediat Infect Disease J"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.089_b0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ppul.20058","article-title":"Respiratory morbidity 20 years after RSV infection in infancy","volume":"38","author":"Korppi","year":"2004","journal-title":"Pediat Pulmonol"},{"issue":"5","key":"10.1016\/j.vaccine.2018.04.089_b0035","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.rmed.2005.08.025","article-title":"Respiratory infections and asthma","volume":"100","author":"Pelaia","year":"2006","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.vaccine.2018.04.089_b0040","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1164\/ajrccm.161.5.9906076","article-title":"Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7","volume":"161","author":"Sigurs","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.089_b0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1164\/rccm.200406-730OC","article-title":"Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13","volume":"171","author":"Sigurs","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.089_b0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/ajot.2002.30634","article-title":"Nasal and otologic effects of experimental respiratory syncytial virus infection in adults","volume":"23","author":"Buchman","year":"2002","journal-title":"Am J Otolaryngol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.089_b0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4049\/jimmunol.107.1.123","article-title":"Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness","volume":"107","author":"Mills","year":"1971","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2018.04.089_b0060","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/rccm.201412-2256OC","article-title":"Impaired antibody-mediated protection and defective IgA B-cell memory in experimental infection of adults with respiratory syncytial virus","volume":"191","author":"Habibi","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.vaccine.2018.04.089_b0065","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/JCM.27.3.589-592.1989","article-title":"Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections","volume":"27","author":"Wagner","year":"1989","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2018.04.089_b0070","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0022-3476(80)80547-6","article-title":"The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses","volume":"96","author":"Welliver","year":"1980","journal-title":"J Pediat"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.04.089_b0075","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0264-410X(01)00287-0","article-title":"Respiratory syncytial virus vaccine development","volume":"20","author":"Crowe","year":"2001","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2018.04.089_b0080","doi-asserted-by":"crossref","first-page":"9790","DOI":"10.1128\/JVI.00530-07","article-title":"Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo","volume":"81","author":"Jewell","year":"2007","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.089_b0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7326\/0003-4819-94-1-53","article-title":"Interferon production in adults with respiratory syncytial viral infection","volume":"94","author":"Hall","year":"1981","journal-title":"Ann Internal Med"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.089_b0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0022-3476(78)80594-0","article-title":"Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections","volume":"93","author":"Hall","year":"1978","journal-title":"J Pediat"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.089_b0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-3476(78)80595-2","article-title":"Interferon in nasal secretions from infants with viral respiratory tract infections","volume":"93","author":"McIntosh","year":"1978","journal-title":"J Pediat"},{"issue":"7","key":"10.1016\/j.vaccine.2018.04.089_b0100","first-page":"212","article-title":"Effect of antilymphocytic serum on circulating interferon in mice as a function of the inducer","volume":"229","author":"de Maeyer-Guignard","year":"1971","journal-title":"Nat: New Biol"},{"issue":"19","key":"10.1016\/j.vaccine.2018.04.089_b0105","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1073\/pnas.1934678100","article-title":"Selective contribution of IFN-alpha\/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection","volume":"100","author":"Honda","year":"2003","journal-title":"Proc Nat Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.089_b0110","first-page":"46","article-title":"Newcastle disease virus as a vaccine vector for humans","volume":"10","author":"Bukreyev","year":"2008","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.vaccine.2018.04.089_b0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","article-title":"Natural killer cells in antiviral defense: function and regulation by innate cytokines","volume":"17","author":"Biron","year":"1999","journal-title":"Ann Rev Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2018.04.089_b0120","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.4049\/jimmunol.169.8.4279","article-title":"Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection","volume":"169","author":"Nguyen","year":"2002","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2018.04.089_b0125","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1084\/jem.20041930","article-title":"Type I interferon dependence of plasmacytoid dendritic cell activation and migration","volume":"201","author":"Asselin-Paturel","year":"2005","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.089_b0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cytogfr.2007.10.006","article-title":"Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history","volume":"19","author":"Fitzgerald-Bocarsly","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"issue":"8","key":"10.1016\/j.vaccine.2018.04.089_b0135","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.174.8.4465","article-title":"Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation","volume":"174","author":"Curtsinger","year":"2005","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2018.04.089_b0140","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1182\/blood-2005-07-2834","article-title":"Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo","volume":"107","author":"Gil","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.vaccine.2018.04.089_b0145","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20050821","article-title":"Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection","volume":"202","author":"Kolumam","year":"2005","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.vaccine.2018.04.089_b0150","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1074-7613(01)00126-1","article-title":"Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo","volume":"14","author":"Le Bon","year":"2001","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.vaccine.2018.04.089_b0155","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.4049\/jimmunol.176.4.2074","article-title":"Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN","volume":"176","author":"Le Bon","year":"2006","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2018.04.089_b0160","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.4049\/jimmunol.176.7.4343","article-title":"Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection","volume":"176","author":"Coro","year":"2006","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.04.089_b0165","first-page":"618","article-title":"Overview of phase I studies of intravenous administration of PV701, an oncolytic virus","volume":"5","author":"Lorence","year":"2003","journal-title":"Curr Opin Mol Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2018.04.089_b0170","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1128\/JVI.80.3.1130-1139.2006","article-title":"Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector","volume":"80","author":"Martinez-Sobrido","year":"2006","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2018.04.089_b0175","first-page":"771","article-title":"The pathogenesis of respiratory syncytial virus infection in cotton rats","volume":"93","author":"Prince","year":"1978","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2018.04.089_b0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.coviro.2015.06.003","article-title":"Animal models of respiratory syncytial virus infection and disease","volume":"13","author":"Sacco","year":"2015","journal-title":"Curr Opin Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2018.04.089_b0185","first-page":"315","article-title":"Acute and chronic airway disease after human respiratory syncytial virus infection in cotton rats (Sigmodon hispidus)","volume":"65","author":"Grieves","year":"2015","journal-title":"Comp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2018.04.089_b0190","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0092-8674(00)81289-1","article-title":"Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease","volume":"84","author":"Durbin","year":"1996","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.vaccine.2018.04.089_b0195","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1128\/JVI.79.10.6035-6042.2005","article-title":"Chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus","volume":"79","author":"Gitiban","year":"2005","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2018.04.089_b0200","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1089\/jir.2006.26.914","article-title":"Interferon-inducible Mx gene expression in cotton rats: cloning, characterization, and expression during influenza viral infection","volume":"26","author":"Pletneva","year":"2006","journal-title":"J Interferon Cytokine Res"},{"issue":"8","key":"10.1016\/j.vaccine.2018.04.089_b0205","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1128\/JVI.01813-10","article-title":"Soluble respiratory syncytial virus fusion protein in the fully cleaved, pretriggered state is triggered by exposure to low-molarity buffer","volume":"85","author":"Chaiwatpongsakorn","year":"2011","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.089_b0210","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/viro.2000.0293","article-title":"Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection","volume":"271","author":"Hallak","year":"2000","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.vaccine.2018.04.089_b0215","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/INF.0b013e318199c3b1","article-title":"Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children","volume":"28","author":"Gomez","year":"2009","journal-title":"Pediat Infect Disease J"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.089_b0220","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1128\/IAI.37.1.397-400.1982","article-title":"Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children","volume":"37","author":"Wright","year":"1982","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2018.04.089_b0225","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0022-3476(76)81044-X","article-title":"Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants","volume":"88","author":"Wright","year":"1976","journal-title":"J Pediat"},{"issue":"11","key":"10.1016\/j.vaccine.2018.04.089_b0230","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S2213-2600(15)00255-6","article-title":"Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics","volume":"3","author":"Mazur","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.vaccine.2018.04.089_b0235","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/528685","article-title":"Viral upper respiratory tract infection and otitis media complication in young children","volume":"46","author":"Chonmaitree","year":"2008","journal-title":"Clin Infect Diseases: Off Publ Infect Diseases Soc Am"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.089_b0240","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/infdis\/jiw475","article-title":"Clinical and socioeconomic burden of respiratory syncytial virus infection in children","volume":"215","author":"Heikkinen","year":"2017","journal-title":"J Infect Diseases"},{"issue":"4","key":"10.1016\/j.vaccine.2018.04.089_b0245","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.04.089_b0250","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J Exp Med"},{"issue":"5 Pt 1","key":"10.1016\/j.vaccine.2018.04.089_b0255","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1203\/pdr.0b013e3180459f5b","article-title":"T helper 1 background protects against airway hyperresponsiveness and inflammation in guinea pigs with persistent respiratory syncytial virus infection","volume":"61","author":"Sutton","year":"2007","journal-title":"Pediatr Res"},{"issue":"7","key":"10.1016\/j.vaccine.2018.04.089_b0260","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1086\/591460","article-title":"Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus","volume":"198","author":"Shinoff","year":"2008","journal-title":"J Infect Diseases"},{"issue":"2","key":"10.1016\/j.vaccine.2018.04.089_b0265","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/421524","article-title":"Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults","volume":"190","author":"Walsh","year":"2004","journal-title":"J Infect Diseases"},{"issue":"6","key":"10.1016\/j.vaccine.2018.04.089_b0270","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1750-2659.2011.00330.x","article-title":"Induction and maintenance of anti-influenza antigen-specific nasal secretory IgA levels and serum IgG levels after influenza infection in adults","volume":"6","author":"Fujimoto","year":"2012","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2018.04.089_b0275","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/mtm.2015.18","article-title":"Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates","volume":"2","author":"Pierantoni","year":"2015","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"300","key":"10.1016\/j.vaccine.2018.04.089_b0280","doi-asserted-by":"crossref","first-page":"300ra127","DOI":"10.1126\/scitranslmed.aac5757","article-title":"Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections","volume":"7","author":"Taylor","year":"2015","journal-title":"Sci Transl Med"},{"issue":"300","key":"10.1016\/j.vaccine.2018.04.089_b0285","doi-asserted-by":"crossref","first-page":"300ra126","DOI":"10.1126\/scitranslmed.aac5745","article-title":"Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults","volume":"7","author":"Green","year":"2015","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.vaccine.2018.04.089_b0290","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/JVI.01946-09","article-title":"Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys","volume":"84","author":"DiNapoli","year":"2010","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.04.089_b0295","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.vaccine.2010.10.024","article-title":"Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response","volume":"29","author":"DiNapoli","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18306091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18306091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T18:11:42Z","timestamp":1693678302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18306091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":59,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0264410X18306091"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}